drug · small molecule
patient view →CLARISCAN
Marketedupdated 2mo agoby $HCA HCA Healthcare, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval, with 1 investigational indication.
all catalysts(7)
approval · 7
Nov 1, 2019
approval
CLARISCAN (GADOTERATE MEGLUMINE) — FDA approval
CLARISCAN
→
Nov 24, 2020
approval
CLARISCAN (GADOTERATE MEGLUMINE) — FDA approval
CLARISCAN
→
Nov 29, 2023
approval
CLARISCAN (GADOTERATE MEGLUMINE) — FDA approval
CLARISCAN
→
Dec 15, 2025
approval
CLARISCAN (GADOTERATE MEGLUMINE) — FDA approval
CLARISCAN
→
Dec 15, 2025
approval
CLARISCAN (GADOTERATE MEGLUMINE) — FDA approval
CLARISCAN
→
Dec 15, 2025
approval
CLARISCAN (GADOTERATE MEGLUMINE) — FDA approval
CLARISCAN
→
Dec 15, 2025
approval
CLARISCAN (GADOTERATE MEGLUMINE) — FDA approval
CLARISCAN
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that